Skip to main content

NEOGENOMICS INC

Data quality: 83%
NEO
Nasdaq Services Engineering & Management Services
$8.00
▼ $0.23 (-2.74%)
Mkt Cap: 1.04 B
Price
$8.00
Mkt Cap
1.04 B
Day Range
$7.77 — $8.25
52-Week Range
$4.72 — $13.74
Volume
634,714
Open $8.19
50D / 200D Avg
$9.76
18.04% below
50D / 200D Avg
$9.31
14.10% below

Quick Summary

Key Takeaways

Negative free cash flow of -21.78 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-12.77%
Above sector avg (-15.95%)
ROIC-7.12%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio3.91
Interest Coverage-30.88

Valuation

PE (TTM)
-9.63
Below sector avg (-1.17)
P/B Ratio1.24
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -9.6 -1.2
P/B 1.2 1.4
ROE % -12.8 -16.0
Net Margin % -19.4
Rev Growth 5Y % 4.0
D/E 0.4

ETFs Holding This Stock

EKG logo EKG First Trust Nasdaq Lux Digital Health Solutions ETF
0.55% weight
DCCCX DCCCX
0.51% weight
DCCIX DCCIX
0.51% weight
DCZRX DCZRX
0.51% weight
DCCRX DCCRX
0.51% weight
GSSSX GSSSX
0.48% weight
GSSUX GSSUX
0.48% weight
GSSMX GSSMX
0.48% weight
GSSIX GSSIX
0.48% weight
GSSCX GSSCX
0.48% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -108.03 M
ROE -12.77% ROA -7.80%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -21.78 M
ROIC -7.12% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.91
Interest Coverage -30.88 Asset Turnover N/A
Working Capital 284.60 M Tangible Book Value 19.78 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9.63 Forward P/E N/A
P/B Ratio 1.24 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -2.09%
Market Cap 1.04 B Enterprise Value 876.38 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0.17 OCF / Share 0.04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 20.16%
SBC-Adj. FCF -63.52 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue
Net Income -108.03 M -78.73 M -87.97 M -144.25 M -8.35 M
EPS (Diluted)
Gross Profit 314.29 M 290.10 M 244.60 M 187.90 M 187.06 M
Operating Income -115.88 M -92.11 M -107.74 M -157.62 M -118.75 M
EBITDA
R&D Expenses 37.08 M 31.16 M 27.31 M 30.33 M 21.87 M
SG&A Expenses
D&A
Interest Expense 3.75 M 6.62 M 6.91 M 1.51 M 5.08 M
Income Tax -2.24 M -1.95 M -9.13 M -15.09 M -6.73 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.36 B 1.64 B 1.68 B 1.74 B 1.87 B
Total Liabilities 523.27 M 735.70 M 739.69 M 742.01 M 761.50 M
Shareholders' Equity 836.56 M 902.34 M 941.54 M 998.02 M 1.11 B
Total Debt 341.86 M 541.11 M
Cash & Equivalents 159.62 M 367.01 M 342.49 M 263.18 M 316.83 M
Current Assets 376.29 M 596.02 M 596.81 M 605.29 M 681.51 M
Current Liabilities 88.30 M 301.24 M 96.30 M 89.93 M 87.23 M